Search Results - "Armbrust, Tammy"

Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages by Maemura, Tadashi, Kuroda, Makoto, Armbrust, Tammy, Yamayoshi, Seiya, Halfmann, Peter J, Kawaoka, Yoshihiro

“…The coronavirus disease 2019 (COVID-19) pandemic has raised concerns about the detrimental effects of antibodies. Antibody-dependent enhancement (ADE) of…”
Get full text

The landscape of antibody binding in SARS-CoV-2 infection by Heffron, Anna S, McIlwain, Sean J, Amjadi, Maya F, Baker, David A, Khullar, Saniya, Armbrust, Tammy, Halfmann, Peter J, Kawaoka, Yoshihiro, Sethi, Ajay K, Palmenberg, Ann C, Shelef, Miriam A, O'Connor, David H, Ong, Irene M

“…The search for potential antibody-based diagnostics, vaccines, and therapeutics for pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has…”
Get full text

Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection by Chiba, Shiho, Halfmann, Peter J, Hatta, Masato, Maemura, Tadashi, Fan, Shufang, Armbrust, Tammy, Swartley, Olivia M, Crawford, LaTasha K, Kawaoka, Yoshihiro

“…Severe acute respiratory syndrome coronavirus 2 readily transmits between domestic cats. We found that domestic cats that recover from an initial infection…”
Get full text

Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters by Halfmann, Peter J., Kuroda, Makoto, Maemura, Tadashi, Chiba, Shiho, Armbrust, Tammy, Wright, Ryan, Balaram, Ariane, Florek, Kelsey R., Bateman, Allen C., Kawaoka, Yoshihiro

“…The emergence of the SARS-CoV-2 Omicron (B.1.1.529) variant with a surprising number of spike mutations raises concerns about reduced sensitivity of this virus…”
Get full text

Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model by Halfmann, Peter J., Kuroda, Makoto, Armbrust, Tammy, Accola, Molly, Valdez, Riccardo, Kowalski-Dobson, Theresa, Rehrauer, William, Gordon, Aubree, Kawaoka, Yoshihiro

“…The emergence of the SARS-CoV-2 Delta variant (B.1.617.2) raises concerns about potential reduced sensitivity of the virus to antibody neutralization and…”
Get full text

Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression by Oda, Shun-Ichiro, Noda, Takeshi, Wijesinghe, Kaveesha J, Halfmann, Peter, Bornholdt, Zachary A, Abelson, Dafna M, Armbrust, Tammy, Stahelin, Robert V, Kawaoka, Yoshihiro, Saphire, Erica Ollmann

“…Marburg virus (MARV), a member of the filovirus family, causes severe hemorrhagic fever with up to 90% lethality. MARV matrix protein VP40 is essential for…”
Get full text

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model by Chiba, Shiho, Kiso, Maki, Nakajima, Noriko, Iida, Shun, Maemura, Tadashi, Kuroda, Makoto, Sato, Yuko, Ito, Mutsumi, Okuda, Moe, Yamada, Shinya, Iwatsuki-Horimoto, Kiyoko, Watanabe, Tokiko, Imai, Masaki, Armbrust, Tammy, Baric, Ralph S, Halfmann, Peter J, Suzuki, Tadaki, Kawaoka, Yoshihiro

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide since December 2019, causing coronavirus disease 2019 (COVID-19). Although…”
Get full text

Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study by Halfmann, Peter J, Eisfeld, Amie J, Watanabe, Tokiko, Maemura, Tadashi, Yamashita, Makoto, Fukuyama, Satoshi, Armbrust, Tammy, Rozich, Isaiah, N'jai, Alhaji, Neumann, Gabriele, Kawaoka, Yoshihiro, Sahr, Foday

“…The 2013-2016 Ebola virus outbreak in West Africa was the largest and deadliest outbreak to date. Here we conducted a serological study to examine the antibody…”
Get full text

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters by Halfmann, Peter J., Iwatsuki-Horimoto, Kiyoko, Kuroda, Makoto, Hirata, Yuichiro, Yamayoshi, Seiya, Iida, Shun, Uraki, Ryuta, Ito, Mutsumi, Ueki, Hiroshi, Furusawa, Yuri, Sakai-Tagawa, Yuko, Kiso, Maki, Armbrust, Tammy, Spyra, Sam, Maeda, Ken, Wang, Zhongde, Imai, Masaki, Suzuki, Tadaki, Kawaoka, Yoshihiro

“…During the Omicron wave, previous variants such as BA.2, BA.4, and BA.5 were replaced by newer variants with additional mutations in the spike protein. These…”
Get full text

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development by Imai, Masaki, Iwatsuki-Horimoto, Kiyoko, Hatta, Masato, Loeber, Samantha, Halfmann, Peter J., Nakajima, Noriko, Watanabe, Tokiko, Ujie, Michiko, Takahashi, Kenta, Ito, Mutsumi, Yamada, Shinya, Fan, Shufang, Chiba, Shiho, Kuroda, Makoto, Guan, Lizheng, Takada, Kosuke, Armbrust, Tammy, Balogh, Aaron, Furusawa, Yuri, Okuda, Moe, Ueki, Hiroshi, Yasuhara, Atsuhiro, Sakai-Tagawa, Yuko, Lopes, Tiago J. S., Kiso, Maki, Yamayoshi, Seiya, Kinoshita, Noriko, Ohmagari, Norio, Hattori, Shin-ichiro, Takeda, Makoto, Mitsuya, Hiroaki, Krammer, Florian, Suzuki, Tadaki, Kawaoka, Yoshihiro

“…At the end of 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) was detected in Wuhan, China, that spread rapidly around…”
Get full text

Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2 by Chiba, Shiho, Halfmann, Peter J., Iida, Shun, Hirata, Yuichiro, Sato, Yuko, Kuroda, Makoto, Armbrust, Tammy, Spyra, Samuel, Suzuki, Tadaki, Kawaoka, Yoshihiro

“…The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a glycoprotein, expressed on the virion surface, that mediates…”
Get full text

Characterization of the SARS-CoV-2 B.1.621 (Mu) variant by Halfmann, Peter J, Kuroda, Makoto, Armbrust, Tammy, Theiler, James, Balaram, Ariane, Moreno, Gage K, Accola, Molly A, Iwatsuki-Horimoto, Kiyoko, Valdez, Riccardo, Stoneman, Emily, Braun, Katarina, Yamayoshi, Seiya, Somsen, Elizabeth, Baczenas, John J, Mitamura, Keiko, Hagihara, Masao, Adachi, Eisuke, Koga, Michiko, McLaughlin, Matthew, Rehrauer, William, Imai, Masaki, Yamamoto, Shinya, Tsutsumi, Takeya, Saito, Makoto, Friedrich, Thomas C, O'Connor, Shelby L, O'Connor, David H, Gordon, Aubree, Korber, Bette, Kawaoka, Yoshihiro

“…The SARS-CoV-2 B.1.621 (Mu) variant emerged in January 2021 and was categorized as a variant of interest by the World Health Organization in August 2021. This…”
Get more information

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses by Halfmann, Peter J., Frey, Steven J., Loeffler, Kathryn, Kuroda, Makoto, Maemura, Tadashi, Armbrust, Tammy, Yang, Jie E., Hou, Yixuan J., Baric, Ralph, Wright, Elizabeth R., Kawaoka, Yoshihiro, Kane, Ravi S.

“…The COVID-19 pandemic continues to cause morbidity and mortality worldwide. Most approved COVID-19 vaccines generate a neutralizing antibody response that…”
Get full text

Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responsesResearch in context by David Pattinson, Peter Jester, Chunyang Gu, Lizheng Guan, Tammy Armbrust, Joshua G. Petrie, Jennifer P. King, Huong Q. Nguyen, Edward A. Belongia, Peter Halfmann, Gabriele Neumann, Yoshihiro Kawaoka

“…Background: World Health Organisation (WHO) and USA Centers for Disease Control and Prevention (U.S. CDC) recommendations now allow simultaneous administration…”
Get full text

Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses by Pattinson, David, Jester, Peter, Gu, Chunyang, Guan, Lizheng, Armbrust, Tammy, Petrie, Joshua G., King, Jennifer P., Nguyen, Huong Q., Belongia, Edward A., Halfmann, Peter, Neumann, Gabriele, Kawaoka, Yoshihiro

“…World Health Organisation (WHO) and USA Centers for Disease Control and Prevention (U.S. CDC) recommendations now allow simultaneous administration of COVID-19…”
Get full text

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronavirusesResearch in context by Peter J. Halfmann, Steven J. Frey, Kathryn Loeffler, Makoto Kuroda, Tadashi Maemura, Tammy Armbrust, Jie E. Yang, Yixuan J. Hou, Ralph Baric, Elizabeth R. Wright, Yoshihiro Kawaoka, Ravi S. Kane

“…Background: The COVID-19 pandemic continues to cause morbidity and mortality worldwide. Most approved COVID-19 vaccines generate a neutralizing antibody…”
Get full text

Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2 by Amjadi, Maya F, O'Connell, Sarah E, Armbrust, Tammy, Mergaert, Aisha M, Narpala, Sandeep R, Halfmann, Peter J, Bashar, S Janna, Glover, Christopher R, Heffron, Anna S, Taylor, Alison, Flach, Britta, O'Connor, David H, Kawaoka, Yoshihiro, McDermott, Adrian B, Sethi, Ajay K, Shelef, Miriam A

“…Lasting immunity will be critical for overcoming COVID-19. However, the factors associated with the development of high titers of anti-SARS-CoV-2 Abs and how…”
Get full text